Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment

There is little or no research initiated on enlightening Nigerians about the pathogenesis, targets for drug development and repositioning for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Coronavirus disease 2019 (COVID-19) is a viral infection causing symptoms like dry cou...

Descripción completa

Detalles Bibliográficos
Autor principal: Muhammed, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association Publishing House. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343650/
https://www.ncbi.nlm.nih.gov/pubmed/32838282
http://dx.doi.org/10.1016/j.bsheal.2020.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343650/
https://www.ncbi.nlm.nih.gov/pubmed/32838282
http://dx.doi.org/10.1016/j.bsheal.2020.07.002

Ejemplares similares